161 related articles for article (PubMed ID: 6360225)
1. The role of placental urokinase inhibitor in toxemia of pregnancy.
Terao T; Kobayashi T
Biol Res Pregnancy Perinatol; 1983; 4(4):145-51. PubMed ID: 6360225
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of placental plasminogen activator (PPA).
Kobayashi T; Terao T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):783-92. PubMed ID: 3923141
[TBL] [Abstract][Full Text] [Related]
3. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
Moniwa N
Pol J Pharmacol; 1996; 48(2):215-20. PubMed ID: 9112654
[TBL] [Abstract][Full Text] [Related]
4. [Fibrinolysis in pregnancy toxemia].
Kano A
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Dec; 35(12):2311-20. PubMed ID: 6607299
[TBL] [Abstract][Full Text] [Related]
5. Human leucocyte urokinase inhibitor--purification, characterization and comparative studies against different plasminogen activators.
Kopitar M; Rozman B; Babnik J; Turk V; Mullins DE; Wun TC
Thromb Haemost; 1985 Dec; 54(4):750-5. PubMed ID: 3879018
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of the reaction between urokinase and an inhibitor of fibrinolysis from placental tissue.
Christensen U; Holmberg L; Bladh B; Astedt B
Thromb Haemost; 1982 Aug; 48(1):24-6. PubMed ID: 6813991
[TBL] [Abstract][Full Text] [Related]
7. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
Nishida Y; Hayashi Y; Imai Y; Itoh H
Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
[TBL] [Abstract][Full Text] [Related]
8. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
Sucak GT; Acar K; Sucak A; Kirazli S; Haznedar R
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):347-52. PubMed ID: 16788310
[TBL] [Abstract][Full Text] [Related]
9. [Fibrinolytic therapy for toxemia of late pregnancy--experimental studies of pregnant rabbits treated with urokinase].
Kano A
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):72-80. PubMed ID: 6699451
[TBL] [Abstract][Full Text] [Related]
10. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia.
Kanfer A; Bruch JF; Nguyen G; He CJ; Delarue F; Flahault A; Nessmann C; Uzan S
Lab Invest; 1996 Jan; 74(1):253-8. PubMed ID: 8569189
[TBL] [Abstract][Full Text] [Related]
11. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
Feng Q; Liu Y; Liu K; Byrne S; Liu G; Wang X; Li Z; Ockleford CD
Placenta; 2000; 21(2-3):184-93. PubMed ID: 10736241
[TBL] [Abstract][Full Text] [Related]
12. Immobilization of plasminogen activator, urokinase, on nylon.
Sugitachi A; Takagi K; Imaoka S; Kosaki G
Thromb Haemost; 1978 Apr; 39(2):426-36. PubMed ID: 580991
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD
Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
[TBL] [Abstract][Full Text] [Related]
14. The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium.
Walker JE; Gow L; Campbell DM; Ogston D
Thromb Haemost; 1983 Feb; 49(1):21-3. PubMed ID: 6221434
[TBL] [Abstract][Full Text] [Related]
15. [Development of Immunoassay of Urinary urokinase inhibitor using biological binding activity of urokinase and urokinase inhibitor (author's transl)].
Yoshio T; Kan S; Ninagawa T
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Apr; 34(4):451-9. PubMed ID: 7040569
[No Abstract] [Full Text] [Related]
16. [Experimental and clinical studies on coagulation and fibrinolysis in toxemia of pregnancy].
Motohara N
Nihon Jinzo Gakkai Shi; 1983 Feb; 25(2):215-26. PubMed ID: 6620689
[No Abstract] [Full Text] [Related]
17. Isolation of peptides with anti-urokinase activity from the human placenta.
Uszynski M
Thromb Haemost; 1980 Feb; 42(5):1411-6. PubMed ID: 6768150
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia.
Estellés A; Gilabert J; España F; Aznar J; Galbis M
Am J Obstet Gynecol; 1991 Jul; 165(1):138-42. PubMed ID: 1906680
[TBL] [Abstract][Full Text] [Related]
19. Coagulation, fibrinolysis, platelet and kinin-forming systems during toxemia of pregnancy.
Maki M
Biol Res Pregnancy Perinatol; 1983; 4(4):152-4. PubMed ID: 6652168
[TBL] [Abstract][Full Text] [Related]
20. [New theory of fibrinolytic mechanism in the development of hyaline membrane disease in newborn infants].
Uszyńska-Folejewska R; Uszyński M
Pediatr Pol; 1975 Dec; 50(12):1513-5. PubMed ID: 127976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
